Bayer AG

OTC: BAYRY · Real-Time Price · USD
7.54
0.01 (0.13%)
At close: Jun 06, 2025, 3:59 PM

Bayer Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
6.19B 4.62B 3.89B 4.72B 5.91B 6.82B 4.48B 4.85B 5.17B 4.36B 3.41B 5.79B 4.56B 4.32B 3.39B 5.55B
Short-Term Investments
1.9B 1.72B 6.14B 4.2B 4.68B 2.49B 3.15B 3.12B 4.98B 4.71B 4.78B 2.41B 3.17B 3.9B 3.11B 3.76B
Long-Term Investments
1.13B 1.38B -1.71B 4.4B 3.45B 330M -352M -315M -2.09B -1.78B -1.99B 268M -563M -1.62B -908M -1.52B
Other Long-Term Assets
3.53B 3.13B 12.27B n/a 1.27B 3.66B 4.36B 4.31B 6.09B 5.84B 5.94B 3.73B 4.59B 5.19B 4.31B 4.81B
Receivables
9.89B n/a 13.44B 14.19B 9.35B 10.53B 13.72B 14.56B 10.32B 11B 14.79B 14.6B 10.05B 10.05B 13.07B 12.97B
Inventory
13.4B 12.95B 13.09B 13.44B 13.95B 13.96B 13.77B 13.53B 13.6B 12.79B 11.37B 10.87B 11.27B 10.64B 10.13B 10.46B
Other Current Assets
2.9B 13.85B 3.59B 3.61B 3.67B 3.73B 3.66B 3.56B 3.65B 5.55B 5.2B 4.58B 3.47B 3.03B 2.75B 3.06B
Total Current Assets
34.44B 33.13B 40.14B 40.17B 37.09B 37.53B 38.78B 39.62B 37.76B 38.41B 39.55B 38.25B 32.58B 31.95B 32.45B 35.8B
Property-Plant & Equipment
13.46B 13.18B 13.49B 13.47B 13.32B 13.45B 13.18B 13.31B 13.67B 13.92B 13.28B 12.79B 12.69B 12.04B 11.83B 11.81B
Goodwill & Intangibles
52.13B 50.25B 55.88B 56.11B 55.66B 57.05B 60.36B 62.61B 63.83B 69.45B 66.95B 65.86B 66.36B 64.39B 62.27B 63.65B
Total Long-Term Assets
76.41B 73.81B 79.72B 79.71B 86.25B 79.71B 82.89B 85.43B 87.12B 92.6B 89.24B 87.54B 87.66B 84.6B 81.98B 82.98B
Total Assets
110.85B 106.95B 119.86B 119.88B 123.34B 117.24B 121.67B 125.05B 124.88B 131.01B 128.79B 125.78B 120.24B 116.55B 114.43B 118.78B
Account Payables
7.52B 6.56B 6.13B 6.4B 7.46B 6.5B 5.97B 6.27B 7.54B 6.55B 6.1B 5.85B 6.79B 5.59B 5.12B 5.19B
Deferred Revenue
n/a n/a n/a 1.28B 3.91B 1.4B 1.66B 1.52B 4.2B 1.79B 2.17B 1.64B 14.31B 1.3B 1.3B 1.17B
Short-Term Debt
4.9B n/a 9.18B 8.28B 4.41B 12.31B 9.96B 9.73B 7.58B 5.33B 6.57B 5.9B 2.82B 4.79B 3.71B 4.95B
Other Current Liabilities
14.79B 17.59B 16.25B 14.67B 14.8B 12.87B 14.6B 16.87B 14.24B 19.5B 18.8B 17.64B 4.12B 17.05B 17.8B 17.63B
Total Current Liabilities
28.95B 25.05B 31.56B 30.63B 29.46B 33.08B 32.19B 34.39B 35.08B 33.17B 33.64B 31.02B 29.4B 28.73B 27.93B 28.93B
Long-Term Debt
34.55B n/a 36.15B 37.99B 37.23B 35.11B 35.35B 33.57B 32.83B 39.46B 36.87B 36.65B 35.55B 36.97B 35.54B 37.92B
Other Long-Term Liabilities
13.15B 50.03B 13.85B 14.32B 7.21B 14.29B 14.56B 14.81B 15.75B 15.65B 17.41B 18.83B 19.49B 18.18B 17.77B 15.1B
Total Long-Term Liabilities
49.85B 51.2B 52.45B 53.49B 60.81B 50.61B 52.36B 49.64B 50.87B 56.37B 56.95B 57.16B 57.67B 56.55B 55.92B 55.07B
Total Liabilities
78.81B 76.25B 84.01B 84.12B 90.27B 83.69B 84.54B 84.03B 85.95B 89.54B 90.59B 88.17B 87.07B 85.28B 83.85B 84B
Total Debt
40.7B n/a 46.58B 46.27B 44.79B 47.42B 46.52B 43.3B 41.32B 44.79B 44.63B 42.55B 39.53B 41.77B 40.37B 42.87B
Common Stock
2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B 2.52B
Retained Earnings
n/a n/a n/a n/a 12.18B n/a n/a n/a 17.23B n/a n/a n/a 13.35B n/a n/a n/a
Comprehensive Income
n/a n/a 33.17B 14.83B -24M 12.6B 16.17B 20.09B 764M 20.5B 17.24B 16.66B -1.1B 10.33B 9.61B 13.81B
Shareholders Equity
31.91B 30.56B 35.69B 35.6B 32.93B 33.38B 36.95B 40.86B 38.77B 41.27B 38.02B 37.44B 33.02B 31.1B 30.39B 34.59B
Total Investments
3.02B 3.1B 4.43B 4.4B 8.13B 2.82B 2.8B 2.81B 2.9B 2.94B 2.79B 2.68B 2.61B 2.28B 2.2B 2.24B